American Capital Advisory »

Cue Biopharma shares owned by American Capital Advisory

Quarter-by-quarter ownership of Cue Biopharma (CUE) shares owned by American Capital Advisory from 13F filings

Historical chart of American Capital Advisory investment in Cue Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Cue Biopharma held by American Capital Advisory consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cue Biopharma by American Capital Advisory

Quarter filed Position value Share count Share price at filing
2024-03-31 $3.6k 1.0k 3.57
2023-12-31 $2.6k 1.0k 2.64

More positions owned by American Capital Advisory

Dimensional Etf Trust Us Core Equity 2 (DFAC)
Schwab Strategic Tr Sht Tm Us Tres (SCHO)
MGM Resorts International. (MGM)
Dimensional Etf Trust Intl Core Equity (DFIC)
Apple (AAPL)
Dimensional Etf Trust Intl Core Eqt Mk (DFAI)
Dimensional Etf Trust Us Core Eqt Mkt (DFAU)
Markel Corporation (MKL)
Dimensional Etf Trust Us Equity Etf (DFUS)
Cisco Systems (CSCO)
State Street Corporation (STT)
Arcos Dorados Holdings Shs Class -a - (ARCO)
Organon & Co Common Stock (OGN)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Meta Platforms Cl A (META)

View all positions for American Capital Advisory

Top funds holding Cue Biopharma

Vanguard Group
BlackRock
Bleichroeder
Geode Capital Management
Robertson Stephens Wealth Management
Dimensional Fund Advisors
Northern Trust
Millennium Management
Monaco Asset Management SAM
Sigma Planning
Bank of America Corporation
GSA Capital Partners
Stifel Financial
Citadel Advisors
Morgan Stanley

View all funds holding Cue Biopharma